home / stock / adma / adma news

ADMA News and Press, ADMA Biologics Inc From 03/23/20

Stock Information
Company Name: ADMA Biologics Inc
Stock Symbol: ADMA
Market: NASDAQ
Website: admabiologics.com
Menu
ADMA ADMA Quote ADMA Short ADMA News ADMA Articles ADMA Message Board
Get ADMA Alerts

News, Short Squeeze, Breakout and More Instantly...
ADMA - SVM, ADMA, AHT and MITT among midday movers

Gainers: Jiayin Group (NASDAQ: JFIN ) +182% . More news on: Jiayin Group Inc., Hoth Therapeutics, Inc., ADMA Biologics, Inc., Stocks on the move, , Read more ...

ADMA - ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2019 Results - Earnings Call Transcript

ADMA Biologics, Inc. (ADMA) Q4 2019 Earnings Conference Call March 12, 2020, 16:30 ET Company Participants Samuel Martin - Argot Partners Adam Grossman - Co-Founder, President, CEO & Director Brian Lenz - EVP & CFO Conference Call Participants Anthony Petrone - Jeff...

ADMA - ADMA Biologics EPS in-line, beats on revenue

ADMA Biologics (NASDAQ: ADMA ): Q4 GAAP EPS of -$0.18 in-line. More news on: ADMA Biologics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

ADMA - ADMA Biologics Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Company Progress

  Achieved Fourth Quarter 2019 Total Revenues of $12.0 Million, a 197% Increase Over Fourth Quarter 2018 Achieved Full Year 2019 Total Revenues of $29.3 Million, a 73% Increase Over Full Year 2018 Strengthened Balance Sheet Through Successful Completion of Underwritten Public...
ADMA - NVAX, SGMO among premarket gainers

Dynatronics (NASDAQ: DYNT ) +224% . More news on: Dynatronics Corporation, Altimmune, Inc., Allied Healthcare Products, Inc., Stocks on the move, , Read more ...

ADMA - ADMA Bio exercises underwriters' over-allotment

ADMA Biologics (NASDAQ: ADMA ) has fully exercised underwriters’ over-allotment option of an additional ~3.5M common shares at $3.50 per share, for gross proceeds of ~$12.3M, bringing the total gross proceeds to ~$94.6M. More news on: ADMA Biologics, Inc., Healthcare stocks n...

ADMA - ADMA Biologics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Connection with Its Public Offering of Common Stock

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 24, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of im...
ADMA - Daily Insider Ratings Round Up 2/11/20

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

ADMA - BBBY, LB, AKAM and ADMS among after hour movers

Gainers: ADMS   +14.9% . SALT   +7.7% . MGI   +3.6% . ADMA   +3.5% . AKAM   +3.2% . More news on: Adamas Pharmaceuticals, Inc., Scorpio Bulkers Inc., MoneyGram International, Inc., Stocks on the move, , , News on ETFs Read more ...

ADMA - ADMA Biologics Receives BioNJ 2020 Innovator Award for ASCENIV(TM)

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 11, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients ...
Previous 10 Next 10